TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
HURA

TuHURA Biosciences Inc

Healthcare · Biotechnology

2.10$ +0.0% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Cash Flow

TuHURA Biosciences Inc (HURA) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2026), "Operating Cash Flow" came in at -28 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow HURA
Line item 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
-3.9 -5.1 -8.0 -9.9 -6.3 -7.9 -19 -6.6 -7.5 -12 -15 -28
– 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.2 0.1 0.1
– – – – – – – 0.7 0.2 0.5 2.0 6.4
0.5 -0.1 -0.5 0.6 1.1 0.5 -2.7 -0.1 1.6 0.5 3.3 -3.1
3.9 0.0 0.0 9.9 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1
– 0.0 0.0 0.0 – – 1.0 0.0 0.0 -1.3 -6.1 -1.3
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
– – – – – – – – 0.0 0.0 0.0 –
– – – – – – – 0.3 -0.4 2.7 29 0.6
0.8 9.6 8.5 9.2 4.1 6.6 26 7.0 16 2.7 30 20
-3.0 4.4 0.4 -0.6 -2.3 -1.3 8.1 0.5 8.7 -11 9.0 -9.0
– -5.1 -8.0 – -6.3 -7.9 -19 -6.6 -7.5 -12 -15 -28

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?